Chloroform → (-)-Acetic acid cis-4-tert-butyloxy-cyclopent-2-enyl ester

HRID 2553

Reaction equation

HRID 2553 reaction equation
[C:1]([O:5][C@@H:6]1[CH2:10][C@H:9]([OH:11])[CH:8]=[CH:7]1)([CH3:4])([CH3:3])[CH3:2].C(N(CC)CC)C.[C:19](OC=C)(=[O:21])[CH3:20].C(Cl)(Cl)Cl>COC(C)(C)C>[C:1]([O:5][C@@H:6]1[CH2:10][C@H:9]([O:11][C:19](=[O:21])[CH3:20])[CH:8]=[CH:7]1)([CH3:4])([CH3:2])[CH3:3]

Participants

6

Procedure

Cis-4-tert-butyloxy-cyclopent-2-enol (485 mg, 3.1 mmol, prepared in example 9) is dissolved in tert-butyl methyl ether (8.6 mL, anhydrous). To the solution is added triethylamine (0.7 eq), pancreatin (3 wt eq, available from Sigma Chemical Company), and vinyl acetate (5 eq). The reaction is allowed to stir for 17 hours at room temperature. The reaction is then filtered through diatomaceous earth and the filtrate is concentrated under vacuum. The products are separated by chromatography on silica gel (10% to 20% ethyl acetate/hexane) to provide (-)-acetic acid cis-4-tert-butyloxy-cyclopent-2-enyl ester (B, 50% yield, 76% ee), [α]D =-10.9°, (c=0.98, chloroform), 1H NMR (CDCl3) δ5.94 (d, 1H, J=5.5 Hz), 5.89 (d, 1H, J=5.5 Hz), 5.46 (appt, 1H, J=5.5 Hz), 4.52 (appt, 1H, J=5.5 Hz), 2.8 (m, 1H), 2.0 (s, 3H), 1.6 (d appt, 1H, J=4.8, 14 Hz), 1.22 (s, 9H); 13C NMR (CDCl3) δ171.2, 138.6, 131.6, 77.4, 77.2, 41, 28.7, 28.6, 21.4; IR (neat) νmax 2976, 1738, 1364, 1242, 1196, 1067, 1020 cm-1 ; CIMS m/e (% relative intensity) 199 (M+H+, 4), 139 (M+H+ -AcOH, 70), 83 (100), and (-)-cis-4-tert-butyloxy-cyclopent-2-enol (A, 194 mg, 40% yield, >98% ee), [α]D 17.2°, (c=1.09, chloroform) as a yellow oil.

Workup

  1. filtrationThe reaction is then filtered through diatomaceous earth
  2. concentrationthe filtrate is concentrated under vacuum
  3. customThe products are separated by chromatography on silica gel (10% to 20% ethyl acetate/hexane)

Sources & evidence

ORD record
ord-1ac771ea14f8470d9583f912bd68a7b3
Source dataset
uspto-grants-1998_03
Patent number
US05728899

Linked notes

Loading…